Agenţia pentru Alimentaţie şi Medicamente din Statele Unite (FDA) a autorizat săptămâna trecută vaccinul anti-COVID-19 dezvoltat de Pfizer şi este pe punctul de a da aviz favorabil şi celui realizat de Moderna. Ambele vaccinuri au o structură similară, dar şi diferenţe notabile, relatează vineri EFE.
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2020/12/injection_5722329_1920_23460800-630x420.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2020/11/screenshot_2020_09_16_at_09_43_56_79529400-752x420.png)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2020/12/injection_5722329_1920_23460800-630x420.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2020/11/vaccine_770_58361900-629x420.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2017/02/istock_000011686797small_58501300-562x420.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2020/11/vaccination_1024x683_47930700-630x420.jpeg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2020/06/masca_coronavirus_67754_71888600-630x420.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2018/03/shutterstock_110115209_w_e1417762766921_700x419_41139600.jpg)
